SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-17-000074
Filing Date
2017-11-09
Accepted
2017-11-09 16:42:17
Documents
67
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20170930x10q.htm 10-Q 1332025
2 EXHIBIT 31.1 gale20170930ex311.htm EX-31.1 8935
3 EXHIBIT 32.1 gale20170930ex321.htm EX-32.1 7771
10 s4pipelinecopy.jpg GRAPHIC 90690
  Complete submission text file 0001390478-17-000074.txt   6372833

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gale-20170930.xml EX-101.INS 1216529
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20170930.xsd EX-101.SCH 56606
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20170930_cal.xml EX-101.CAL 72686
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20170930_def.xml EX-101.DEF 209514
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20170930_lab.xml EX-101.LAB 643708
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20170930_pre.xml EX-101.PRE 368762
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 171191450
SIC: 2834 Pharmaceutical Preparations